Valeant Pharmaceuticals International Inc (TSE:VRX) - Share price - Overview

Stock Report

Valeant Pharmaceuticals International Inc VRX

Last Price
CAD32.77

Day Change
0.54|1.68%

As of 20/06/2018
16:00:00 EDT | CAD
Minimum 15 Minutes Delay.

Last Close32.23
Day Range32.12 - 32.95
Mkt Cap11.45Bil
52-Wk Range14.01 - 36.02
Yield %-
ISINCA91911K1021
Volume1,273,932
P/E-
P/S1.01
P/CF4.89

Share Price

Financials
201520162017
More ...
Income Statement
Revenue10,446.509,674.008,724.00
Operating Income2,409.301,125.00538.00
Net Income-291.70-2,409.002,404.00
Basic EPS-0.85-6.946.86
Avg. Diluted Shares Outstanding343347352
Balance Sheet
Current Assets5,507.205,077.004,746.00
Non Current Assets43,457.3038,452.0032,751.00
Total Assets48,964.5043,529.0037,497.00
Current Liabilities5,312.603,609.004,268.00
Total Liabilities---
Total Equity5,911.003,152.005,849.00
Cash Flow
Operating Cash Flow2,200.402,087.002,290.00
Capital Expenditure-303.30-291.00-336.00
Free Cash Flow1,897.101,796.001,954.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Mid-Value

Fiscal Year Ends

December

Employees

20,700
Key Stats
More ...
Price/Earning TTM-
Price/Book1.92
Price/Sales TTM-
Rev Growth (3 year avg)1.82
EPS Growth (3 year avg)-
Operating Margin % TTM6.17
Net Margin % TTM27.56
ROE TTM53.42
Debt/Equity4.31
Dividends
PreviousLatest
More ...
Declared Date06/08/1005/11/10
Ex-Div30/08/1010/11/10
Paid04/10/1022/12/10
Amnt0.101.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.